Acute and chronic dosing of the GABA A alpha 2,3 selective agonist BAER-101 do not alter behavior but may impact auditory-evoked EEG responses in adults with fragile X syndrome. - De Stefano LA; Kim H; Erickson CA; Pedapati EV; Dominick KC; Shaffer R; Wink LK; Schmitt LM; Miyakoshi M (Scientific reports, 2026)